Collaborations aim to develop new drugs for neglected tropical diseasesBMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b2638 (Published 29 June 2009) Cite this as: BMJ 2009;338:b2638
- Janice Hopkins Tanne
- 1New York
The Drugs for Neglected Diseases Initiative meeting in Nairobi, Kenya, on 23 June heard promising news about collaborations to develop drugs to treat neglected tropical diseases.
The meeting brought together more than 200 scientists, researchers, academics, and global health leaders from Africa and abroad to consider new treatments for diseases such as visceral leishmaniasis (kala-azar), Chagas’ disease, and sleeping sickness.
The initiative said that better treatments are needed by millions of the world’s poorest people. Current treatments are often toxic, prohibitively expensive, or difficult to administer in countries with limited resources. Drug companies have little incentive to develop treatments for neglected diseases that mainly …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial